Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
J Am Coll Cardiol
; 61(23): 2355-62, 2013 Jun 11.
Article
en En
| MEDLINE
| ID: mdl-23583763
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Propanolaminas
/
Carbazoles
/
Enalapril
/
Disfunción Ventricular Izquierda
/
Neoplasias Hematológicas
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Am Coll Cardiol
Año:
2013
Tipo del documento:
Article
País de afiliación:
España